Arkolith/Insider Trading/LEXX/Form 4

Christopher Richard

Chief Executive Officer, DirectorLexaria Bioscience Corp. (LEXX) · full profile →Form 4 · filed Jul 30, 2025
Net Buying
Open-Market Buys
$14K
Open-Market Sells
$0
Net Open-Market Flow
$14K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 29, 2025Buy(P)15K$0.91$14K65K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001348362-25-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML